We recently updated our soy research page with a 2019 dose-response meta-analysis of 23 prospective studies. It included a total of 330,826 participants and found that both soy protein and soy isoflavones had a positive impact on breast cancer mortality (1). A 10 mg/day increase in soy isoflavone intake was associated with a 9% decreased risk of breast cancer mortality, and a 5 g/day increase in soy protein intake was associated with a 12% reduction in breast cancer death (1).
You may also like
Hello– You’re receiving this email because you signed up for blog posts from JackNorrisRD.com. I haven’t made a post since last September, […]
by Jack Norris, RD Entire article is Bone Fractures among U.K. Vegans: Implications and Recommendations. [Correction (February 21, 2021): A reader pointed […]
Based on our recent re-analysis of vitamin B12 needs, Vitamin B12: Rationale for Recommendations, in which we determined that methylmalonic acid (MMA) […]
by Jack Norris, RD, LD We’ve added two appendices to our article, Omega-3s Part 2: Research: Appendix A: Biomarkers of DHA Status […]